Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Maisieres, P. D.-T.
Right arrow Articles by Piette, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Maisieres, P. D.-T.
Right arrow Articles by Piette, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 22, 13636-13644, May 29, 1998

Activation of the Human Immunodeficiency Virus Long Terminal Repeat by Varicella-zoster Virus IE4 Protein Requires Nuclear Factor-kappa B and Involves Both the Amino-terminal and the Carboxyl-terminal Cysteine-rich Region

Patricia Defechereux-Thibaut de MaisieresDagger , Laurence Baudoux-TebacheDagger , Marie-Paule Mervilleparallel , Bernard RentierDagger , Vincent Boursparallel , and Jacques PietteDagger

From the Dagger  Laboratory of Fundamental Virology and Immunology and parallel  Laboratory of Medical Chemistry and Medical Oncology, Institute of Pathology, University of Liège, B-4000 Liège, Belgium

Varicella-zoster virus open reading frame 4-encoded protein (IE4) possesses transactivating properties for varicella-zoster virus genes as well as for those of heterologous viruses such as the human immunodeficiency virus type 1 (HIV-1). Mechanisms of HIV-1 LTR (long terminal repeat) transactivation were investigated in HeLa cells transiently transfected with an IE4 expression plasmid and a CAT reporter gene under the control of the HIV-1 LTR. These results demonstrated that IE4-mediated transactivation of the HIV-1 LTR in HeLa cells required transcription factor kappa B (NF-kappa B). Using the gel retardation assay, it was shown that transfection of the IE4 expression vector in HeLa cells was not associated with induction of NF-kappa B under the p50·p65 heterodimeric form and that no direct binding of IE4 to the kappa B sites could be detected. Both Western blot and immunofluorescence analyses suggested that the ability of IE4 to activate transcription through kappa B motives was not connected with its capacity to override the inhibitory activities of Ikappa B-alpha or p105. Finally, in vitro protein-protein interactions involving IE4 and basal transcription factors such as TATA-binding protein and transcription factor IIB were carried out. A direct interaction between IE4 and TATA-binding protein or transcription factor IIB components of the basal complex of transcription was evidenced, as well as binding to the p50 and p65 NF-kappa B subunits. Mutagenesis analysis of IE4 indicated that the COOH-terminal cysteine-rich and arginine-rich regions (residues 82-182) were critical for transactivation, whereas the first 81 amino acids appeared dispensable. Moreover, the arginine-rich region is required for the in vitro binding activity, whereas the COOH-terminal end did not appear essential.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
J. I. Cohen, T. Krogmann, J. P. Ross, L. Pesnicak, and E. A. Prikhod'ko
Varicella-Zoster Virus ORF4 Latency-Associated Protein Is Important for Establishment of Latency
J. Virol., June 1, 2005; 79(11): 6969 - 6975.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Sato, M. Sommer, H. Ito, and A. M. Arvin
Requirement of Varicella-Zoster Virus Immediate-Early 4 Protein for Viral Replication
J. Virol., November 15, 2003; 77(22): 12369 - 12372.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Baudoux, P. Defechereux, B. Rentier, and J. Piette
Gene Activation by Varicella-Zoster Virus IE4 Protein Requires Its Dimerization and Involves Both the Arginine-rich Sequence, the Central Part, and the Carboxyl-terminal Cysteine-rich Region
J. Biol. Chem., October 13, 2000; 275(42): 32822 - 32831.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement